New Brunswick Health officials say they're keeping a close eye on vaccine supplies in the province.
This comes after Health Canada issued a recommendation not to use the influenza vaccine Agriflu made by Novartis, after discoveries of clumping of particles in the vaccine in Europe.
Chief Medical Officer of Health Dr. Eilish Cleary says some of the influenza vaccine distributed in the province was Agriflu, but she hasn't received reports of health problems or clumping particles from it. Cleary adds people who've had the influenza vaccine shouldn't be unduly concerned.
Around 50,000 doses of Agriflu have been distributed across the province.
Influenza clinics will continue using the vaccine Fluviral.